Chlamydia trachomatis PCR (Cobas Amplicor) in women: endocervical specimen transported in a specimen of urine versus endocervical and urethral specimens in 2-SP medium versus urine specimen only

Int J STD AIDS. 2000 Oct;11(10):651-8. doi: 10.1258/0956462001915011.

Abstract

The sensitivity of Roche Cobas Amplicor Chlamydia trachomatis polymerase chain reaction (PCR) including the internal control (IC) programme to identify inhibition, was investigated on 3 different samples from women: (1) swab samples from the urethra and the cervix pooled in 2-SP transport medium, (2) swab sample from the cervix transported in a urine sample from the same patient, and (3) urine sample alone. Out of the 2412 patients, 193 (8.0%) were chlamydia positive and in 14 of these the results showed discrepancies between sampling methods. The sensitivity of PCR on urethra/cervix, urine/cervix and urine was 98.4% (190/193), 97.9% (189/193) and 93.3% (180/193) respectively. The higher sensitivity of PCR on urethra/cervix and urine/cervix as compared with urine alone was statistically significant. Without the IC, the sensitivity of PCR on urethra/ cervix, urine/cervix and urine would have been 95.9% (185/193), 94.8% (183/193) and 90.7% (175/193) respectively. Factors influencing the rate of inhibition were also studied.

Publication types

  • Comparative Study

MeSH terms

  • Cervix Uteri / microbiology
  • Chlamydia Infections / epidemiology
  • Chlamydia Infections / microbiology*
  • Chlamydia Infections / urine
  • Chlamydia trachomatis / genetics
  • Chlamydia trachomatis / isolation & purification*
  • Female
  • Female Urogenital Diseases / epidemiology
  • Female Urogenital Diseases / microbiology*
  • Female Urogenital Diseases / urine
  • Humans
  • Polymerase Chain Reaction / methods
  • Reagent Kits, Diagnostic
  • Sensitivity and Specificity
  • Specimen Handling / methods
  • Sweden / epidemiology
  • Urethra / microbiology
  • Vaginal Smears

Substances

  • Reagent Kits, Diagnostic